TrialJAMA network open2020

Assessment of Plasma Amyloid-β42/40 and Cognitive Decline Among Community-Dwelling Older Adults.

Kelly Virecoulon Giudici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.